Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

InSound Medical

Request full access

California-based venture-backed company that develops and manufactures hearing devices and systems

Newark, United StatesFounded 1998Biotech & Life Sciences

About InSound Medical

InSound Medical, Inc. operated as a medical device company, establishing its position by developing and manufacturing advanced hearing aid solutions. Founded in 1998 by medical device entrepreneur Adnan Shennib and Dr. Robert Schindler, an ear, nose, and throat specialist, the company sought to address a primary barrier to hearing aid adoption: the stigma associated with visibility. Shennib, a serial inventor with experience at firms like ReSound, guided the company as Chairman, President, and CEO until 2003, leveraging his background in biomedical engineering and his experience in developing novel medical technologies.

The company's flagship product, the Lyric®, represented a significant development in the hearing aid market as the first 100% invisible, extended-wear hearing device. Engineered over a decade, the Lyric is designed to be placed deep within the ear canal, just millimeters from the eardrum, by a certified hearing professional without surgery. This deep placement utilizes the natural anatomy of the ear to funnel sound, which provides a more natural listening experience and helps to reduce background noise and feedback. The device is constructed from a soft, biocompatible foam and is engineered to be worn continuously, 24/7, for months at a time—even during activities like showering, exercising, and sleeping. This removes the daily maintenance tasks associated with traditional hearing aids, such as changing batteries or daily insertion and removal.

InSound Medical's business model was centered on selling the Lyric device through a network of authorized audiologists and hearing healthcare practices. After commercially launching in the U.S. in 2008, the company saw strong sales growth. This success culminated in its acquisition by Sonova Holding AG, a global leader in hearing systems, on January 6, 2010. The transaction consisted of an initial $75 million cash payment, with subsequent earn-out payments tied to financial performance, which were later settled for a one-off payment of $94 million to fully integrate InSound Medical's distribution. Following the acquisition, InSound Medical was set to operate as an independent business unit, leveraging Sonova's resources to expand distribution and further innovate on the Lyric platform, which has since been updated with newer versions by Sonova's brand, Phonak.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
1,059
Open positions
None listed
Dealroom signal
30.0/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2C

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Jan 2010 $75M $75M Sonova Holding —
DEBTDebt Sep 2009 $2.9M — Undisclosed —
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

InSound Medical website traffic

Latest recorded traffic for InSound Medical is 0 monthly website visits. InSound Medical's team declined 16.9% over the past year.

Latest monthly visits0 1-year team growth-16.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

InSound Medical in the Newark ecosystem

Live from Dealroom

The InSound Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Essex Woodlands Health Ventures
  • EW Healthcare Partners

Series B and later6 investors entered at this stage

  • Johnson & Johnson Development Corporation
  • ESSEX WOODLANDS HEALTH VENTURES UK LIMITED
  • PIPER JAFFRAY LTD.
  • DeNovo Ventures
  • Psilos Group
  • CMEA Capital

Other known investors1 additional known investor

  • Sonova Holding
Team profiled 36 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
38 countries with
team presence
🇺🇸 United States46.7%
🇨🇭 Switzerland12.9%
🇫🇷 France5.3%
🇧🇷 Brazil5%
🇬🇧 United Kingdom4.4%
Top 5 of 38 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about InSound Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See InSound Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.